EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy

Michela Palmisani iD, Francesca Dattrino iD, Paola Rota iD, Federica Tacchella, Guido Fedele, Ludovica Pasca, Carlo Alberto Quaranta iD, Valentina De Giorgis iD, Thomas Matulli Cavedagna iD, Chiara Cancellerini iD, Anna Butti, Gloria Castellazzi und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Michela Palmisani und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Cannabidiol, Drug Monitoring, Epilepsy. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the Italian Ministry of Education, University and Research (MIUR), the Italian Ministry of Health through the "5x1000" program (IRC…, Italian Ministry of Education, University, and Research (MIUR), Italian Ministry of Health through the “5 × 1000” program (IRCCS Mondino Foundation, Pavia, Italy).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study describes the development and validation of a fully automated workflow for serum sample preparation, enabling the quantitative determination of cannabidiol (CBD) and its active metabolite, 7-hydroxy-CBD, via liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) analysis. Implemented on an automated platform, the workflow performs key steps such as solvent dispensing, mixing, centrifugation, filtration, and supernatant transfer, producing 96-well plates ready for analysis. Human serum samples were obtained from patients with epilepsy treated with CBD. All samples were processed using both manual and automated methods to evaluate method agreement. Quantification was performed by LC–MS/MS with CBD-d3 as the internal standard (IS). Method validation was conducted in accordance with European Medicine Agency (EMA) guidelines, confirming that the automated protocol meets the recommended acceptance criteria for both intraday and interday precision and accuracy. Calibration curves demonstrated excellent linearity across the concentration ranges. Comparative analysis using Passing–Bablok regression and Bland–Altman plots demonstrated strong agreement between the methods. These findings support the clinical applicability of the automated method for the therapeutic drug monitoring (TDM) of CBD and 7-hydroxy-CBD, and its robust performance and scalability provide a solid foundation for the development of an expanded analytical panel covering a broader range of antiseizure medications (ASMs), enabling more standardized TDM protocols in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryCannabidiolDrug MonitoringEpilepsyAnticonvulsantsHumansChromatography, LiquidWorkflowReproducibility of ResultsLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

7-hydroxy-CBDCBDLC-MS/MSTDMautomationepilepsy

Substanzen

CannabidiolAnticonvulsants

Autor:innen und Institutionen

  • Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
  • IRCCS Mondino Foundation, 27100 Pavia, Italy.
  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20133 Milan, Italy.
  • Institute for Molecular and Translational Cardiology (IMTC), San Donato Milanese, 20097 Milan, Italy.
  • Associazione Farmaceutici dell'Industria (AFI), 20149 Milan, Italy.
  • Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

ORCID-Profile: Michela Palmisani, Francesca Dattrino, Paola Rota, Carlo Alberto Quaranta, Valentina De Giorgis, Thomas Matulli Cavedagna, Chiara Cancellerini, Emilio Russo, Cristina Tassorelli

Förderung

  • This research was funded by the Italian Ministry of Education, University and Research (MIUR), the Italian Ministry of Health through the "5x1000" program (IRC…
  • Italian Ministry of Education, University, and Research (MIUR)
  • Italian Ministry of Health through the “5 × 1000” program (IRCCS Mondino Foundation, Pavia, Italy)
  • Regione Lombardia within the framework of the Innodriver-S3 2019 initiative
  • POR FESR 2014–2020 program

Zitieren

APA

Palmisani, M., Dattrino, F., Rota, P., Tacchella, F., Fedele, G., Pasca, L., Quaranta, C. A., De Giorgis, V., Matulli Cavedagna, T., Cancellerini, C., Butti, A., Castellazzi, G., Russo, E., Tassorelli, C., Nicotera, P., & Franco, V. (2025). Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146999

Vancouver

Palmisani M, Dattrino F, Rota P, Tacchella F, Fedele G, Pasca L, et al. Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146999

BibTeX
@article{Palmisani2025,
  author = {Palmisani, Michela and Dattrino, Francesca and Rota, Paola and Tacchella, Federica and Fedele, Guido and Pasca, Ludovica and Quaranta, Carlo Alberto and De Giorgis, Valentina and Matulli Cavedagna, Thomas and Cancellerini, Chiara and Butti, Anna and Castellazzi, Gloria and Russo, Emilio and Tassorelli, Cristina and Nicotera, Pierluigi and Franco, Valentina},
  title = {Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146999}
}
Kostenlos starten →